Skip to main content
Livermore
Livermore
ZHEN

Janus Henderson Group PLC

SEC CIK
0001274173
Latest filing
May 18, 2026

RLAY holding history

Relay Therapeutics, Inc. in every 13F filed by Janus Henderson Group PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RLAY overviewAll 13F holders of RLAYFull Q1 2026 holdings

Shares (Q1 2026)
65,573
Value
$652.1K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of RLAY by Janus Henderson Group PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 202665,573$652.1K<0.1%+28,700+77.8%AddedHolders
Q4 202536,873$312.5K<0.1%00.0%UnchangedHolders
Q3 202536,873$192.7K<0.1%00.0%UnchangedHolders
Q2 202536,873$127.8K<0.1%00.0%UnchangedHolders
Q1 202536,873$100.1K<0.1%00.0%UnchangedHolders
Q4 202436,873$152.1K<0.1%00.0%UnchangedHolders
Q3 202436,873$260.5K<0.1%00.0%UnchangedHolders
Q2 202436,873$240.6K<0.1%−469−1.3%ReducedHolders
Q1 202437,342$309.2K<0.1%+29+0.1%AddedHolders
Q4 202337,313$410.3K<0.1%−58−0.2%ReducedHolders
Q3 202337,371$314.1K<0.1%−30.0%ReducedHolders
Q2 202337,374$469.0K<0.1%−46−0.1%ReducedHolders
Q1 202337,420$616.9K<0.1%+19,090+104.1%AddedHolders
Q4 202218,330$273.7K<0.1%+6,200+51.1%AddedHolders
Q3 202212,130$271.0K<0.1%−4,652−27.7%ReducedHolders
Q2 202216,782$281.0K<0.1%+16,782NewHolders
Q4 20210$00.0%−17,004−100.0%Sold outHolders
Q3 202117,004$534.0K<0.1%−7,236−29.9%ReducedHolders
Q2 202124,240$884.0K<0.1%−68,690−73.9%ReducedHolders
Q1 202192,930$3.21M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.